(Q42672686)

English

Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan

scientific article published on 17 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

9

object named as

Kazunori Oishi

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Kenji Kawakami

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Yasushi Ohkusa

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Reiki Kuroki

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Takeshi Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kazuhiko Koyama

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Yoshitaka Harada

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kouichi Iwanaga

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Takeshi Yamaryo

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

17 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

7063-7069

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

The burden of community-acquired pneumonia in seniors: results of a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Pneumococcal vaccination of elderly adults: new paradigms for protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Economic foundations of cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

The challenge of subgroup analyses--reporting without distorting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Statistics in medicine--reporting of subgroup analyses in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Risk factors for acquiring pneumococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Community-acquired pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

High incidence of silent aspiration in elderly patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Benefits of pneumococcal vaccination for bedridden patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.010

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.08.010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42672686&oldid=1965183217"